Literature DB >> 1559358

Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome.

G Zilow1, T Joka, U Obertacke, U Rother, M Kirschfink.   

Abstract

OBJECTIVE: To determine the generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome (ARDS).
DESIGN: Prospective study.
SETTING: ICU in a university hospital. PATIENTS: Severely traumatized patients at risk for the ARDS (n = 25). INTERVENTION: EDTA plasma samples and bronchoalveolar lavage fluid were obtained.
MEASUREMENTS AND MAIN RESULTS: Complement proteins C3, C4, C5, and the inhibitors C1-inhibitor, Factor H, and Factor I were quantitated in EDTA-plasma samples obtained every 6 hrs during the first 48 hrs after ICU admission and every morning from days 4 to 14 after injury. In bronchoalveolar lavage fluid, the complement activation production of C3a-desArg was quantitated and the volume of epithelial lining fluid was calculated. All patients showed a decrease of the complement proteins C3, C4, C5 and of the inhibitors C1-inhibitor, Factor H, and Factor I during the first 24 hrs, indicating complement consumption. Patients developing ARDS (n = 11) showed significantly higher C3 concentrations and a higher C3a/C3 ratio in the first few hours after multitrauma. Follow-up bronchoalveolar lavages demonstrated highly increased amounts of C3a in epithelial lining fluid during the first 24 hrs, mainly in ARDS patients and, to a lesser degree, in non-ARDS patients. To determine the origin of C3a in bronchoalveolar lavages, the ratio of C3a in epithelial lining fluid and plasma was calculated.
CONCLUSION: The C3a of epithelial lining fluid to plasma ratio was extremely high in patients developing ARDS, but even the non-ARDS group had a ratio greater than 1, indicating that a substantial local complement activation occurs in the lung.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559358     DOI: 10.1097/00003246-199204000-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  15 in total

1.  Early complementopathy after multiple injuries in humans.

Authors:  Anne-Maud Burk; Myriam Martin; Michael A Flierl; Daniel Rittirsch; Matthias Helm; Lorenz Lampl; Uwe Bruckner; Gregory L Stahl; Anna M Blom; Mario Perl; Florian Gebhard; Markus Huber-Lang
Journal:  Shock       Date:  2012-04       Impact factor: 3.454

2.  Activation of the complement system generates antibacterial peptides.

Authors:  Emma Andersson Nordahl; Victoria Rydengård; Patrik Nyberg; D Patric Nitsche; Matthias Mörgelin; Martin Malmsten; Lars Björck; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

3.  Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Authors:  S Stöve; T Welte; T O Wagner; A Kola; A Klos; W Bautsch; J Köhl
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing.

Authors:  Stefan Recknagel; Ronny Bindl; Julian Kurz; Tim Wehner; Philipp Schoengraf; Christian Ehrnthaller; Hongchang Qu; Florian Gebhard; Markus Huber-Lang; John D Lambris; Lutz Claes; Anita Ignatius
Journal:  J Orthop Res       Date:  2011-09-15       Impact factor: 3.494

Review 5.  The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.

Authors:  Nohora Cristina Ayola-Serrano; Namrata Roy; Zareena Fathah; Mohammed Moustapha Anwar; Bivek Singh; Nour Ammar; Ranjit Sah; Areej Elba; Rawan Sobhi Utt; Samuel Pecho-Silva; Alfonso J Rodriguez-Morales; Kuldeep Dhama; Sadeq Quraishi
Journal:  Inflamm Res       Date:  2021-06-04       Impact factor: 6.986

Review 6.  New insights of an old defense system: structure, function, and clinical relevance of the complement system.

Authors:  Christian Ehrnthaller; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mol Med       Date:  2010-10-29       Impact factor: 6.354

Review 7.  Complement After Trauma: Suturing Innate and Adaptive Immunity.

Authors:  Shinjini Chakraborty; Ebru Karasu; Markus Huber-Lang
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

8.  Complement Activation and Organ Damage After Trauma-Differential Immune Response Based on Surgical Treatment Strategy.

Authors:  Ina Lackner; Birte Weber; Meike Baur; Giorgio Fois; Florian Gebhard; Roman Pfeifer; Paolo Cinelli; Sascha Halvachizadeh; Miriam Lipiski; Nikola Cesarovic; Hubert Schrezenmeier; Markus Huber-Lang; Hans-Christoph Pape; Miriam Kalbitz
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

9.  Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia.

Authors:  Friso de Beer; Wim Lagrand; Gerie J Glas; Charlotte J P Beurskens; Gerard van Mierlo; Diana Wouters; Sacha Zeerleder; Joris J T H Roelofs; Nicole P Juffermans; Janneke Horn; Marcus J Schultz
Journal:  Cell Biochem Biophys       Date:  2016-09-28       Impact factor: 2.194

Review 10.  Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.

Authors:  Ludmila Lupu; Annette Palmer; Markus Huber-Lang
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.